Evidence map›Paper›PMID 40316613›Full record

ArticleScientific reports2025

Interpretable machine learning model for predicting post-hepatectomy liver failure in hepatocellular carcinoma.

Tianzhi Tang, Tianyu Guo, Bo Zhu, Qihui Tian, Yang Wu, Yefu Liu

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tianzhi TangDepartment of Hepatobiliary and Pancreatic Surgery, Cancer Hospital of China Medical University/Liaoning Cancer Hospital & Institute, Shenyang, Liaoning Province, People's Republic of China.ORCID http://orcid.org/0009-0009-8651-9615
Tianyu GuoDepartment of Hepatobiliary and Pancreatic Surgery, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning Province, People's Republic of China.
Bo ZhuDepartment of Cancer Prevention and Treatment, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning Province, People's Republic of China.
Qihui TianDepartment of Cancer Prevention and Treatment, Cancer Hospital of China Medical University/Liaoning Cancer Hospital & Institute, Shenyang, Liaoning Province, People's Republic of China.
Yang WuMedical Oncology Department of Thoracic Cancer (2), Liaoning Cancer Hospital & Institute, Shenyang, 110042, Liaoning Province, People's Republic of China. 18900917796@163.com.
Yefu LiuDepartment of Hepatobiliary and Pancreatic Surgery, Liaoning Cancer Hospital & Institute, No.44 Xiaoheyan Road, Dadong District, Shenyang, 110042, Liaoning Province, People's Republic of China. 97902153@cmu.edu.cn.

Funding

Liaoning Provincial Key Laboratory of Precision Medicine for Malignant Tumors Project number: 220569
6 · The paper itself

Abstract

Post-hepatectomy liver failure (PHLF) is a severe complication following liver surgery. We aimed to develop a novel, interpretable machine learning (ML) model to predict PHLF. We enrolled 312 hepatocellular carcinoma (HCC) patients who underwent hepatectomy, and 30% of the samples were utilized for internal validation. Variable selection was performed using the least absolute shrinkage and selection operator regression in conjunction with random forest and recursive feature elimination (RF-RFE) algorithms. Subsequently, 12 distinct ML algorithms were employed to identify the optimal prediction model. The area under the receiver operating characteristic curve, calibration curves, and decision curve analysis (DCA) were utilized to assess the model's predictive accuracy. Additionally, an independent prospective validation was conducted with 62 patients. The SHapley Additive exPlanations (SHAP) analysis further explained the extreme gradient boosting (XGBoost) model. The XGBoost model exhibited the highest accuracy with AUCs of 0.983 and 0.981 in the training and validation cohorts among 12 ML models. Calibration curves and DCA confirmed the model's accuracy and clinical applicability. Compared with traditional models, the XGBoost model had a higher AUC. The prospective cohort (AUC = 0.942) further confirmed the generalization ability of the XGBoost model. SHAP identified the top three critical variables: total bilirubin (TBIL), MELD score, and ICG-R15. Moreover, the SHAP summary plot was used to illustrate the positive or negative effects of the features as influenced by XGBoost. The XGBoost model provides a good preoperative prediction of PHLF in patients with resectable HCC.

Indexed as

Carcinoma, HepatocellularHepatectomyLiver FailureLiver NeoplasmsMachine LearningPostoperative ComplicationsAdultAgedAlgorithmsFemaleHumansMaleMiddle AgedProspective StudiesROC CurveHepatocellular carcinomaMachine learningPost-hepatectomy liver failurePrediction model

Identifiers

PMID40316613
PMCPMC12048636

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.